[Effect of the in vivo and in vitro MOPOC 315 treatment on contact sensitivity to DNFB in mice. Inhibition of the suppressive activity of splenic suppressor cells by the in vitro MOPC 315 treatment (author's transl)].
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D003877:Dermatitis, Contact / Q000209:etiology / Q000276:immunology*; D004139:Dinitrofluorobenzene / Q000276:immunology*; D008297:Male; D051379:Mice; D009194:Myeloma Proteins / Q000276:immunology*; D009578:Nitrobenzenes / Q000276:immunology*; D013154:Spleen / Q000166:cytology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
D000911:Antibodies, Monoclonal; D009194:Myeloma Proteins; D009578:Nitrobenzenes; D004139:Dinitrofluorobenzene